Enrique Carrera

542 total citations
15 papers, 154 citations indexed

About

Enrique Carrera is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Enrique Carrera has authored 15 papers receiving a total of 154 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Hepatology and 3 papers in Surgery. Recurrent topics in Enrique Carrera's work include Liver Disease Diagnosis and Treatment (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). Enrique Carrera is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). Enrique Carrera collaborates with scholars based in Argentina, Peru and United States. Enrique Carrera's co-authors include Ângelo Zambam de Mattos, José D. Debes, Domingo Balderramo, Jhon Prieto, Marco Arrese, Ángela Lamarca, André Boonstra, Juan Carlos Roa, Patricia García and M. Isabel Lucena and has published in prestigious journals such as Alimentary Pharmacology & Therapeutics, Digestive Diseases and Sciences and Cancers.

In The Last Decade

Enrique Carrera

15 papers receiving 153 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Enrique Carrera Argentina 8 63 61 35 29 28 15 154
Varun Kesar United States 6 70 1.1× 40 0.7× 29 0.8× 48 1.7× 17 0.6× 50 181
Jiguang Ding China 8 63 1.0× 46 0.8× 17 0.5× 35 1.2× 12 0.4× 13 182
Clara Mancuso Italy 8 61 1.0× 72 1.2× 39 1.1× 56 1.9× 24 0.9× 10 193
Naijuan Yao China 10 146 2.3× 123 2.0× 17 0.5× 36 1.2× 20 0.7× 31 265
Ane Zamalloa United Kingdom 7 96 1.5× 73 1.2× 19 0.5× 23 0.8× 16 0.6× 21 162
Alice U Lee Australia 5 135 2.1× 154 2.5× 46 1.3× 12 0.4× 26 0.9× 7 247
Toru Setsu Japan 11 129 2.0× 108 1.8× 10 0.3× 72 2.5× 24 0.9× 35 315
Jinjian Yao China 10 40 0.6× 25 0.4× 30 0.9× 17 0.6× 24 0.9× 23 177
М. V. Maevskaya Russia 7 142 2.3× 78 1.3× 37 1.1× 19 0.7× 26 0.9× 34 206

Countries citing papers authored by Enrique Carrera

Since Specialization
Citations

This map shows the geographic impact of Enrique Carrera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enrique Carrera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enrique Carrera more than expected).

Fields of papers citing papers by Enrique Carrera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enrique Carrera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enrique Carrera. The network helps show where Enrique Carrera may publish in the future.

Co-authorship network of co-authors of Enrique Carrera

This figure shows the co-authorship network connecting the top 25 collaborators of Enrique Carrera. A scholar is included among the top collaborators of Enrique Carrera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enrique Carrera. Enrique Carrera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Prieto, Jhon, Ângelo Zambam de Mattos, Ângelo Alves de Mattos, et al.. (2023). Epidemiology and risk factors for histopathologic characteristics of non‐alcoholic fatty liver disease in South America. Alimentary Pharmacology & Therapeutics. 58(5). 526–536. 1 indexed citations
2.
Fu, Siyu, Jhon Prieto, Domingo Balderramo, et al.. (2023). Assessment of TLL1 variant and risk of hepatocellular carcinoma in Latin Americans and Europeans. Annals of Hepatology. 29(2). 101181–101181. 3 indexed citations
3.
Prieto, Jhon, Domingo Balderramo, Ângelo Zambam de Mattos, et al.. (2023). MBOAT7 rs641738 Variant Is Not Associated with an Increased Risk of Hepatocellular Carcinoma in a Latin American Cohort. Digestive Diseases and Sciences. 68(11). 4212–4220. 3 indexed citations
4.
Anugwom, Chimaobi M., Jhon Prieto, Domingo Balderramo, et al.. (2023). Assessment of STAT4 Variants and Risk of Hepatocellular Carcinoma in Latin Americans and Europeans. Cancers. 15(18). 4530–4530. 2 indexed citations
5.
Fu, Siyu, Domingo Balderramo, Ângelo Zambam de Mattos, et al.. (2023). Validation and optimization of AFP-based biomarker panels for early HCC detection in Latin America and Europe. Hepatology Communications. 7(10). 15 indexed citations
6.
Anugwom, Chimaobi M., Ângelo Zambam de Mattos, Marco Arrese, et al.. (2022). Changing epidemiology of hepatocellular carcinoma in South America: A report from the South American liver research network. Annals of Hepatology. 28(2). 100876–100876. 20 indexed citations
7.
Fonseca, Leonardo Gomes da, Laura Izquierdo‐Sánchez, Enrique Carrera, et al.. (2021). P-10 LATIN AMERICAN REGISTRY OF CHOLANGIOCARCINOMA: CLINICAL FEATURES, MANAGEMENT AND OUTCOMES. Annals of Hepatology. 24. 100376–100376. 1 indexed citations
8.
Balderramo, Domingo, Ângelo Zambam de Mattos, Denusa Wiltgen, et al.. (2021). Abnormal Liver Tests during Hospitalization Predict Mortality in Patients with COVID‐19: A Multicenter Study from South America. Canadian Journal of Gastroenterology and Hepatology. 2021(1). 1622533–1622533. 9 indexed citations
9.
García, Patricia, et al.. (2020). Current and New Biomarkers for Early Detection, Prognostic Stratification, and Management of Gallbladder Cancer Patients. Cancers. 12(12). 3670–3670. 22 indexed citations
10.
Carrera, Enrique, et al.. (2019). High Prevalence of Multidrug Resistant Bacteria in Cirrhotic Patients with Spontaneous Bacterial Peritonitis: Is It Time to Change the Standard Antimicrobial Approach?. Canadian Journal of Gastroenterology and Hepatology. 2019. 1–6. 13 indexed citations
11.
Debes, José D., Enrique Carrera, Ângelo Zambam de Mattos, Jhon Prieto, & André Boonstra. (2019). Hepatocellular carcinoma, a unique tumor with a lack of biomarkers. Annals of Hepatology. 18(6). 786–787. 12 indexed citations
12.
Bessone, Fernando, Nelia Hernández, Manuel Mendizábal, et al.. (2019). Cuando la creación de un consorcio proporciona respuestas útiles: experiencia de la Latin American DILI network (LATINDILIN). Clinical Liver Disease. 13(S1). S17–S23. 3 indexed citations
13.
Bessone, Fernando, Nelia Hernández, Manuel Mendizábal, et al.. (2019). When the Creation of a Consortium Provides Useful Answers: Experience of The Latin American DILI Network (LATINDILIN). Clinical Liver Disease. 13(2). 51–57. 27 indexed citations
14.
Balderramo, Domingo, Enrique Carrera, Fernando Javier Barreyro, et al.. (2018). PIB: A Score to Select Sorafenib Treatment Candidates for Hepatocellular Carcinoma in Resource-Limited Settings. Hepatitis Monthly. In Press(In Press). 2 indexed citations
15.
Balderramo, Domingo, Enrique Carrera, Fernando Javier Barreyro, et al.. (2018). Sorafenib for Treatment of Hepatocellular Carcinoma. Journal of Clinical Gastroenterology. 53(6). 464–469. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026